Serum adiponectin is associated with family history of diabetes independently of obesity and insulin resistance in healthy Korean men and women

European Journal of Endocrinology

Volumn 160, Issue 1, 2009, Pages 39-43

  Sull, Jae Woong ^a   Kim, Hee Jin ^a   Yun, Ji Eun ^a   Kim, Grace ^b   Park, Eun Jung ^a,c   Kim, Soriul ^a,c   Lee, Hee Yeon ^a,c   Jee, Sun Ha ^a  

^a Yonsei University   (South Korea)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Metabolic Syndrome Research Initiatives   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ADIPONECTIN, HUMAN; CHOLESTEROL; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; KOREA; MALE; OBESITY; POPULATION RISK; PRIORITY JOURNAL; RISK FACTOR; SMOKING; WAIST CIRCUMFERENCE; AGED; BLOOD; CROSS-SECTIONAL STUDY; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; STATISTICAL MODEL;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN RESISTANCE; KOREA; LINEAR MODELS; MALE; MIDDLE AGED; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 58249089603     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0603     Document Type: Article

References (24)

1. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Boqardus C & Tataranni PA. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002 51 1884-1888.
2. Bacci S, Menzaghi C, Ercolino T, Ma X, Rauseo A, Salvemini L, Vigna C, Fanelli R, Di Mario U, Doria A & Trischitta V. The + 276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004 27 2015-2020.
3. Kita A, Yamasaki H, Kuwahara H, Moriuchi A, Fukushima K, Kobayashi M, Fukushima T, Takahashi R, Abiru N, Uotani S, Kawasaki E & Eguchi K. Identification of the promoter region required for human adiponectin gene transcription: association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha. Biochemical and Biophysical Research Communications 2005 331 484-490.
4. Fasshauer M, Klein J, Neumann S, Eszlinger M & Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications 2002 290 1084-1089.
5. Filippi E, Sentinelli F, Trischitta V, Romeo S, Arca M, Leonetti F, Di Mario U & Baroni MG. Association of the human adiponectin gene and insulin resistance. European Journal of Human Genetics 2004 12 199-205.
6. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P & Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001 7 941-946.
7. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Haseqawa K, Muraquchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T & Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 1595-1599.
8. Diez JJ & Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. European Journal of Endocrinology 2003 148 293-300.
9. Pellmé F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR & Jansson PA. Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes 2003 52 1182-1186.
10. Behre CJ, Brohall G, Hulthe J & Fagerberg B. Serum adiponectin in a population sample of 64-year-old women in relation to glucose tolerance, family history of diabetes, autoimmunity, insulin sensitivity, C-peptide, and inflammation. Metabolism 2006 55 188-194.
11. Civitarese AE, Jenkinson CP, Richardson D, Bajaj M, Cusi K, Kashyap S, Berria R, Belfort R, DeFronzo RA, Mandarino LJ & Ravussin E. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia 2004 47 816-820.
12. Kowalska I, Straczkowski M, Nikolajuk A, Krukowska A, Kinalska I & Górska M. Plasma adiponectin concentration and tumor necrosis factor alpha system activity in lean non-diabetic offspring of type 2 diabetic subjects. European Journal of Endocrinology 2006 154 319-324.
13. Tesauro M, Rizza S, Iantorno M, Campia U, Cardillo C, Lauro D, Leo R, Turriziani M, Cocciolillo GC, Fusco A, Panza JA, Scuteri A, Federici M, Lauro R & Quon MJ. Vascular, metabolic, and inflammatory abnormalities in normoglycemic offspring of patients with type 2 diabetes mellitus. Metabolism 2007 56 413-419.
14. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, Staiger H, Maerker E, Häring H & Stumvoll M. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 2003 52 239-243.
15. Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA & Campbell LV. Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects. Diabetes Care 2004 27 2033-2040.
16. Retnakaran R, Connelly PW, Sermer M, Zinman B & Hanley AJ. The impact of family history of diabetes on risk factors for gestational diabetes. Clinical Endocrinology 2007 67 754-760.
17. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE & Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Journal of Clinical Endocrinology and Metabolism 2001 86 1930-1935.
18. Yoon SJ, Lee HS, Lee SW, Yun JE, Kim SY, Cho E, Lee SJ, Lee EJ, Lee HY, Park J, Kim HS & Jee SH. The association between adiponectin and diabetes in the Korean population. Metabolism 2008 57 853-857.
19. Takefuji S, Yatsuya H, Tamakoshi K, Otsuka R, Wada K, Matsushita K, Sugiura K, Hotta Y, Mitsuhashi H, Oiso Y & Toyoshima H. Smoking status and adiponectin in healthy Japanese men and women. Preventive Medicine 2007 45 471-475.
20. Abbasi F, Farin HM, Lamendola C, McLaughlin T, Schwartz EA, Reaven GM & Reaven PD. The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. Journal of Clinical Endocrinology and Metabolism 2006 91 5002-5007.
21. Iwashima Y, Katsuya T, Ishikawa K, Kida I, Ohishi M, Horio T, Ouchi N, Ohashi K, Kihara S, Funahashi T, Rakugi H & Ogihara T. Association of hypoadiponectinemia with smoking habit in men. Hypertension 2005 45 1094-1100.
22. Pischon T, Hotamisligli GS & Rimm EB. Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clinical Chemistry 2003 49 650-652.
23. DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabetic Medicine 2006 23 857-866.
24. Rhee BD. Epidemiological characteristics of diabetes mellitus among Korean population. Journal of Korean Diabetes Association 2003 27 173-178.